These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 10208500)
1. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency. Hegele RA; Little JA; Connelly PW Atherosclerosis; 1999 Mar; 143(1):219-22. PubMed ID: 10208500 [No Abstract] [Full Text] [Related]
2. Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipients. Silverstein DM Pediatr Transplant; 2003 Feb; 7(1):7-10. PubMed ID: 12581321 [No Abstract] [Full Text] [Related]
3. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related]
4. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin. Singhal MK; Bhaskaran S; Szabo T; La Rosa R Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354 [No Abstract] [Full Text] [Related]
5. Atorvastatin and low-density lipoprotein subfractions profile in mixed hyperlipidaemia: a contributory effect of reduced hepatic lipase activity? Heller F; Descamps O; Hondekijn JC; Desager JP Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():788-9. PubMed ID: 10586326 [No Abstract] [Full Text] [Related]
6. Atorvastatin and fibrinogen--a small subgroup shows extreme response. Sinzinger H; Rodrigues M Atherosclerosis; 1999 Aug; 145(2):415-7. PubMed ID: 10488971 [No Abstract] [Full Text] [Related]
10. Variable influence of statins on isoprostanes in hyperlipidemia. Sinzinger H; Oguogho A Adv Exp Med Biol; 2003; 525():209-12. PubMed ID: 12751770 [No Abstract] [Full Text] [Related]
11. High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia. Wierzbicki AS; Lumb PJ; Chik G; Crook MA Am J Cardiol; 2000 Sep; 86(5):547-9, A9. PubMed ID: 11009276 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia. Malhotra HS; Goa KL Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study. Aguilar-Salinas CA; Gómez-Pérez FJ; Posadas-Romero C; Vázquez-Chávez C; Meaney E; Gulías-Herrero A; Guillén LE; Alvarado Vega A; Mendoza Pérez E; Eduardo Romero-Nava L; Angélica Gómez-Díaz R; Salinas-Orozco S; Moguel R; Novoa G Atherosclerosis; 2000 Oct; 152(2):489-96. PubMed ID: 10998478 [TBL] [Abstract][Full Text] [Related]
15. Elevated lipoprotein(a) with statin therapy. Spielberg T Am J Cardiol; 2000 May; 85(9):1162. PubMed ID: 10896622 [No Abstract] [Full Text] [Related]
16. More on switching statins: comments from Pfizer. Lloyd K BMJ; 2006 Sep; 333(7569):655; author reply 655-6. PubMed ID: 16990337 [No Abstract] [Full Text] [Related]
17. [Drug clinics. Drug of the month. Atorvastatin (Lipitor)]. Scheen AJ Rev Med Liege; 1998 Jun; 53(6):374-7. PubMed ID: 9713220 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia]. Liguori E; Sarcinella R Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861 [No Abstract] [Full Text] [Related]
19. The nature of the statins. Jones PH Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539 [No Abstract] [Full Text] [Related]
20. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation. Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]